Healio

Tofacitinib provides sustained dactylitis improvement in psoriatic arthritis

Please provide your email address to receive an email when new articles are posted on . “Dactylitis is considered a core domain of musculoskeletal symptoms in PsA and is important for both patients ...
Healio

Dactylitis, enthesitis resolution linked to less pain, fatigue in guselkumab-treated PsA

Please provide your email address to receive an email when new articles are posted on . Patients who achieved enthesitis resolution were more likely to have improvements in pain and physical function.
MedPage Today

Guselkumab, a Selective IL-23 p19 Subunit Inhibitor, Resolves Dactylitis in Active PsA: Pooled Results Through Week 52 From Two Phase 3 Studies

Dennis McGonagle, Iain B. McInnes, Atul Deodhar, Georg Schett, May Shawi, Soumya D. Chakravarty, Alexa P. Kollmeier, Xie L. Xu, Shihong Sheng, Stephen Xu, Christopher ...
Medscape

Apremilast New Oral Option for Psoriatic Arthritis

ROME — Apremilast (Otezla, Celgene), a new oral option for the treatment of psoriatic arthritis, shows sustained and clinically meaningful improvement in key symptoms of the disease out to 104 weeks, ...